Assisted Reproductive
Technology (ART) Program Reporting System
Revision of a currently approved collection
No
Regular
12/20/2024
Requested
Previously Approved
36 Months From Approved
12/31/2024
416,242
308,225
297,352
219,904
43,512
10,115,670
The Centers for Disease Control and
Prevention (CDC) is currently approved to collect information
needed to determine the annual pregnancy success rate of each
clinic that provides assisted reproductive technology (ART)
services (“Assisted Reproductive Technology Program Reporting
System,” OMB No. 0920-0556, exp. 7/31/2018). This data collection
is required by The Fertility Clinic Success Rate and Certification
Act (FCSRCA), Section 2(a) of P.L. 102-493(42 USC 263 (a)-1) which
mandates ART clinics to submit information to CDC and requires CDC
to publish pregnancy success rates. CDC seeks OMB approval on a
revision request to revise burden estimates, modify data elements
to align with current clinical practice, and extend information
collection for an additional three years. Compared to the burden
previously approved, the total annualized burden requested is
higher due to an increase in the average number of ART cycles
performed per clinic, due to an overall increase in the utilization
of ART in the United States.
US Code:
42
USC 301 Name of Law: Public Health Service Act
PL:
Pub.L. 102 - 493 2 (a) Name of Law: Fertility Clinic Success
Rate and Certification Act
CDC revised burden hour
estimates and modify data elements collected. Data elements
collected will be modified to remove two data elements no longer
needed and add one new data element to reflect current clinical
practice. CDC will remove the requirement for clinics to report
dosage information for long-acting FSH because they are not
approved for use in the United States. CDC will remove the
requirement for clinics to report the research cycle study type
because additional information on research cycle study type is not
necessary to report pregnancy success rates. CDC will add the
requirement for clinics to report date of fresh embryo
cryopreservation for all frozen embryo transfer procedures because
it will improve reporting of factors that impact ART success rates.
A revised data collection form is provided in Attachment C1. The
proposed changes are not anticipated to impact the burden hours to
report data for ART cycles.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.